Search Page

1

Cite

Glucose-lowering drugs, cognition, and dementia: The clinical evidence.

Wu CY, Shapiro L, Ouk M, MacIntosh BJ, Black SE, Shah BR, Swardfager W. Wu CY, et al. Among authors: ouk m. Neurosci Biobehav Rev. 2022 Jun;137:104654. doi: 10.1016/j.neubiorev.2022.104654. Epub 2022 Apr 6. Neurosci Biobehav Rev. 2022. PMID: 35398114 Review.

Cite

2

Cite

Endosomal-Lysosomal and Autophagy Pathway in Alzheimer's Disease: A Systematic Review and Meta-Analysis.

Krance SH, Wu CY, Chan ACY, Kwong S, Song BX, Xiong LY, Ouk M, Chen MH, Zhang J, Yung A, Stanley M, Herrmann N, Lanctôt KL, Swardfager W. Krance SH, et al. Among authors: ouk m. J Alzheimers Dis. 2022;88(4):1279-1292. doi: 10.3233/JAD-220360. J Alzheimers Dis. 2022. PMID: 35754279

Cite

3

Cite

Biofluid markers of blood-brain barrier disruption and neurodegeneration in Lewy body spectrum diseases: A systematic review and meta-analysis.

Wong YY, Wu CY, Yu D, Kim E, Wong M, Elez R, Zebarth J, Ouk M, Tan J, Liao J, Haydarian E, Li S, Fang Y, Li P, Pakosh M, Tartaglia MC, Masellis M, Swardfager W. Wong YY, et al. Among authors: ouk m. Parkinsonism Relat Disord. 2022 Aug;101:119-128. doi: 10.1016/j.parkreldis.2022.06.004. Epub 2022 Jun 20. Parkinsonism Relat Disord. 2022. PMID: 35760718

Cite

4

Cite

Neutrophil activation in Alzheimer's disease and mild cognitive impairment: A systematic review and meta-analysis of protein markers in blood and cerebrospinal fluid.

Wu CY, Bawa KK, Ouk M, Leung N, Yu D, Lanctôt KL, Herrmann N, Pakosh M, Swardfager W. Wu CY, et al. Among authors: ouk m. Ageing Res Rev. 2020 Sep;62:101130. doi: 10.1016/j.arr.2020.101130. Epub 2020 Jul 23. Ageing Res Rev. 2020. PMID: 32712109

Cite

5

Cite

Gastric acid suppressants and cognitive decline in people with or without cognitive impairment.

Wu CY, Xiong LY, Ouk M, Rabin JS, Herrmann N, Lanctôt KL, Kapral MK, Law M, Cogo-Moreira H, Edwards JD, Swardfager W. Wu CY, et al. Among authors: ouk m. Alzheimers Dement (N Y). 2022 Feb 10;8(1):e12243. doi: 10.1002/trc2.12243. eCollection 2022. Alzheimers Dement (N Y). 2022. PMID: 35169610 Free PMC article.

Cite

6

Cite

Psychiatric morbidity and cervical cancer screening: a retrospective population-based case-cohort study.

Ouk M, Edwards JD, Colby-Milley J, Kiss A, Swardfager W, Law M. Ouk M, et al. CMAJ Open. 2020 Mar 10;8(1):E134-E141. doi: 10.9778/cmajo.20190184. Print 2020 Jan-Mar. CMAJ Open. 2020. PMID: 32161045 Free PMC article.

Cite

7

Cite

Associations between brain amyloid accumulation and the use of angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers.

Ouk M, Wu CY, Rabin JS, Edwards JD, Ramirez J, Masellis M, Swartz RH, Herrmann N, Lanctôt KL, Black SE, Swardfager W; Alzheimer’s Disease Neuroimaging Initiative. Ouk M, et al. Neurobiol Aging. 2021 Apr;100:22-31. doi: 10.1016/j.neurobiolaging.2020.12.011. Epub 2020 Dec 16. Neurobiol Aging. 2021. PMID: 33461049

Cite

8

Cite

Perivascular spaces mediate a relationship between diabetes and other cerebral small vessel disease markers in cerebrovascular and neurodegenerative diseases.

Zebarth J, Kamal R, Perlman G, Ouk M, Xiong LY, Yu D, Lin WZ, Ramirez J, Masellis M, Goubran M, MacIntosh BJ, Black SE, Cogo-Moreira H, Scott CJM, Bartha R, Symons S, Haddad SMH, Ozzoude M, Nanayakkara N, Beaton D, Arnott S, Dowlatshahi D, Swartz RH, Saposnik G, Grimes D, Lang A, Fischer CE, Frank A, Kumar S, Pollock BG, Tang-Wai D, Finger E, Rabin JS, Swardfager W. Zebarth J, et al. Among authors: ouk m. J Stroke Cerebrovasc Dis. 2023 Sep;32(9):107273. doi: 10.1016/j.jstrokecerebrovasdis.2023.107273. Epub 2023 Aug 3. J Stroke Cerebrovasc Dis. 2023. PMID: 37542762

Cite

9

Cite

Depression and Diabetes Mellitus Multimorbidity Is Associated With Loss of Independence and Dementia Poststroke.

Ouk M, Wu CY, Colby-Milley J, Fang J, Zhou L, Shah BR, Herrmann N, Lanctôt KL, Linkewich E, Law M, Swartz RH, Kapral MK, Black SE, MacIntosh BJ, Edwards JD, Swardfager W. Ouk M, et al. Stroke. 2020 Dec;51(12):3531-3540. doi: 10.1161/STROKEAHA.120.031068. Epub 2020 Oct 14. Stroke. 2020. PMID: 33226916

Cite

10

Cite

Leukotriene receptor antagonist use and cognitive decline in normal cognition, mild cognitive impairment, and Alzheimer's dementia.

Xiong LY, Ouk M, Wu CY, Rabin JS, Lanctôt KL, Herrmann N, Black SE, Edwards JD, Swardfager W. Xiong LY, et al. Among authors: ouk m. Alzheimers Res Ther. 2021 Sep 3;13(1):147. doi: 10.1186/s13195-021-00892-7. Alzheimers Res Ther. 2021. PMID: 34479635 Free PMC article.

Cite